Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 4 studies | 43% ± 23% | |
GABAergic neuron | 3 studies | 39% ± 15% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 33% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 628.55 | 226 / 226 | 21% | 0.70 | 86 / 406 |
pancreas | 100% | 388.04 | 328 / 328 | 0% | 0 | 0 / 178 |
brain | 82% | 189.83 | 2177 / 2642 | 1% | 0.01 | 4 / 705 |
kidney | 78% | 27.12 | 69 / 89 | 1% | 0.01 | 6 / 901 |
prostate | 78% | 33.72 | 190 / 245 | 0% | 0.00 | 1 / 502 |
thymus | 73% | 24.78 | 478 / 653 | 0% | 0.00 | 1 / 605 |
stomach | 69% | 31.04 | 247 / 359 | 2% | 0.03 | 7 / 286 |
skin | 71% | 41.35 | 1280 / 1809 | 0% | 0 | 0 / 472 |
ovary | 68% | 25.03 | 122 / 180 | 1% | 0.02 | 6 / 430 |
uterus | 63% | 23.98 | 107 / 170 | 1% | 0.01 | 4 / 459 |
bladder | 52% | 17.05 | 11 / 21 | 1% | 0.02 | 7 / 504 |
spleen | 49% | 12.53 | 117 / 241 | 0% | 0 | 0 / 0 |
esophagus | 46% | 19.54 | 668 / 1445 | 1% | 0.02 | 2 / 183 |
lung | 45% | 14.47 | 261 / 578 | 1% | 0.01 | 11 / 1155 |
breast | 42% | 14.57 | 195 / 459 | 1% | 0.01 | 8 / 1118 |
adrenal gland | 27% | 7.83 | 70 / 258 | 11% | 0.18 | 26 / 230 |
intestine | 30% | 8.57 | 287 / 966 | 2% | 0.04 | 9 / 527 |
blood vessel | 23% | 6.11 | 310 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 22% | 13.28 | 200 / 929 | 0% | 0 | 0 / 0 |
adipose | 12% | 3.06 | 149 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 7% | 0.09 | 3 / 45 |
heart | 4% | 0.76 | 31 / 861 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.02 | 1 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0042981 | Biological process | regulation of apoptotic process |
GO_0006537 | Biological process | glutamate biosynthetic process |
GO_0006543 | Biological process | glutamine catabolic process |
GO_0006520 | Biological process | amino acid metabolic process |
GO_0072593 | Biological process | reactive oxygen species metabolic process |
GO_0005739 | Cellular component | mitochondrion |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0004359 | Molecular function | glutaminase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | GLS2 |
Protein name | Alternative protein GLS2 Truncated glutaminase 2 (EC 3.5.1.2) glutaminase (EC 3.5.1.2) Glutaminase 2 Glutaminase liver isoform, mitochondrial (GLS) (EC 3.5.1.2) (L-glutaminase) (L-glutamine amidohydrolase) |
Synonyms | GA hCG_24976 |
Description | FUNCTION: Plays an important role in the regulation of glutamine catabolism. Promotes mitochondrial respiration and increases ATP generation in cells by catalyzing the synthesis of glutamate and alpha-ketoglutarate. Increases cellular anti-oxidant function via NADH and glutathione production. May play a role in preventing tumor proliferation. . |
Accessions | ENST00000610413.4 F8WEU7 Q9UI32 Q0VD99 C9J3Q2 ENST00000461077.1 ENST00000486896.5 [Q9UI32-2] ENST00000486433.5 F8WBC9 ENST00000479952.5 F8WBL8 ENST00000483347.1 ENST00000424141.6 ENST00000311966.9 [Q9UI32-1] L0R6H3 G5E9X4 E5G744 A0A087X004 ENST00000623608.3 A8K0A6 ENST00000494474.5 ENST00000539272.5 E5G745 E5G743 |